Taken together, the findings of this study indicate that naringin can activate the Nrf2/HO-1 signaling pathway in the liver, and that these effects may contribute to the reduction of oxidative stress, inflammation and NAFLD progression. The gene discussed is NFE2L2; the disease is metabolic dysfunction-associated steatotic liver disease.